首页> 外文学位 >Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

【24h】

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
Harada Yasuhiko; 原田靖彦;
展开▼
作者单位

名古屋大学;

展开▼
授予单位名古屋大学;
学科
学位博士
年度 2019
页码 1-8
总页数 8
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-17 11:59:06

相似文献

外文文献
中文文献
专利

1. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [J] . Harada Yasuhiko, Nagata Yasunobu, Kihara Rika, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2018,第期

机译：预后分析根据2017年ELN风险分层对日本成人白血病研究组（JALSG）AML201研究中的成人急性髓性白血病患者的遗传学
2. Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study. [J] . Ohtake S, Miyawaki S, Fujita H, Blood: The Journal of the American Society of Hematology . 2011,第8期

机译：在以前未接受过治疗的急性髓性白血病成年患者中，将标准剂量伊达比星与大剂量柔红霉素比较的诱导疗法随机研究：JALSG AML201研究。
3. A 17-Gene Leukemia Stem Cell (LSC) Score in Adult Patients (Pts) with Acute Myeloid Leukemia (AML) Reveals a Distinct Mutational Landscape and Refines Current European Leukemianet (ELN) Genetic Risk Stratification [J] . Bill Marius, Nicolet Deedra, Eisfeld Ann-Kathrin, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：17基因白血病干细胞（LSC）中成年患者（PTS）的评分急性髓性白血病（AML）揭示了一个不同的突变景观，并改善目前的欧洲白血病（ELN）遗传风险分层
4. Treating acute myeloid leukemia via HSC transplantation: A preliminary study of multi-objective personalization strategies [C] . Chakrabarty, Ankush, Pearce, American Control Conference . 2013

机译：通过HSC移植治疗急性髓细胞性白血病：多目标个性化策略的初步研究
5. Evidence for heterogeneous genetic associations with acute lymphoblastic leukemia (ALL) by cytogenetics, age, and sex in high-risk patients treated with matched unrelated donor allogeneic blood or marrow transplant (URD-BMT) [D] . Clay, Alyssa I. 2016

机译：通过匹配的无关供体同种异体造血或骨髓移植（URD-BMT）治疗的高危患者中，通过细胞遗传学，年龄和性别进行的与急性淋巴细胞白血病（ALL）异质遗传关联的证据
6. 1018. Prevalence of Bacteremia/Fungemia and Pneumonia in Remission Induction Chemotherapy for Adult Acute Myeloid Leukemia From 1987 to 2005: Japan Adult Leukemia Study Group (JALSG) [O] . Hideaki Kato, Hiroyuki Fujita, Nobu Akiyama, -1

机译：1018.从1987年至2005年成人急性髓样白血病的缓解诱导化疗中细菌/真菌和肺炎的流行：日本成人白血病研究组（JALSG）
7. Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study [O] . Noriko Usui, Akihiro Takeshita, Chiaki Nakaseko, 2011

机译：阶段I试验Gemtuzumab ozogamicin在密集的组合化疗复发或难治性成人急性髓性白血病（AML）：日本成人白血病研究组（JALSG）-AML206研究

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

著录项

相似文献

相关主题

期刊订阅